CHIESI GROUP LAUNCH NEW PRODUCT INTO UK £80 MILLION ASTHMA MARKET

Chiesi Group announces the UK launch of Clenil Modulite (beclometasone dipropionate [BDP), a new CFC-free metered-dose inhaler (MDI) by their UK affiliate Trinity-Chiesi Pharmaceuticals. There are several CFC-free reliever inhalers currently available in the UK but Clenil Modulite is only the second CFC-free preventer (BDP) inhaler in this market.
PR Web